At early stage of the infection, sTLR9 was increasingly expressed in the infiltrated CD11b+ PMNs, and IL-17 was increasingly expressed in both of the CD11b− PMNs and CD11b+ PMNs. The gene discussed is IL17A; the disease is infection.